CE High Molecular Weight Stable Medical Sodium Hyaluronate Gel Joint Injection

Name: CE High Molecular Weight Stable Medical Sodium Hyaluronate Gel Joint Injection
Brand: QUFU HI-TECH TRADING CO., LTD.
SKU: 1925005386

Shandong, ChinaQUFU HI-TECH TRADING CO., LTD.

US$10.00

5-99 Pieces

US$9.00

100-299 Pieces

US$8.00

300-499 Pieces

US$7.00

500+ Pieces

Sample price:US$15.00/piece.Request sample

Product profile

Customization

Available

Supply Type

OEM/ODM

Suitable for

Adult

Model NO.

2ml

Application

for Therapy, for Prevention

Form

Gel

Ingredient

Hyaluronic Acid

Color

Transparent

Source

Bio-Fermentation

Content

1%-3%

Material

Pure Hyaluronic Acid

Certificate

ISO GMP MSDS

Technology

Non Cross-Linked

Dosage Form

Liquid Gel

Transport Package

One Syringe Per Box

Specification

19× 7.5× 2.5

Trademark

TOP-Q

Origin

Shandong, China

Production Capacity

10000pieces/Month

Company profile

Fast DeliveryFull CustomizationFlexible CustomizationHigh Repeat Buyers Choice

QUFU HI-TECH TRADING CO., LTD.

Shandong, China

Business Type: Manufacturer/FactoryExport Year: 2010-08-01Nearest Port: Qingdao, Shanghai, ShenzhenAverage Response Time: ≤6.22hTerms of Payment: T/T, PayPal, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, FCA, CPT

AI-Powered supplier vetting

SummaryThe supplier demonstrates established medical-device-related capabilities through ISO 13485 and GMP certifications, ODM/OEM services, recent product development, customization options, stated dermal filler output, inventory capability, and participation in Dubai Derma. It reports 11–20 years of total R&D engineer experience and 6–10 quality-control staff. Service procedures for corrective and preventive actions and customer complaints are documented and supported by records. However, it does not provide 3D software design services, overseas agents or branches, overseas warehouses, or overseas showrooms. Raw-material traceability, outsourcing controls, and quality-assurance status are unknown. Financial information is available only as reporting-year labels, so financial credibility cannot be determined from the provided data.

Supplier typeThe supplier’s stated business scope covers broad trading categories and import/export of goods and technology, while other slices identify factory operations in Qufu, Shandong, ISO 13485/GMP certification, and ODM/OEM services. This supports classifying it as a manufacturing-oriented supplier with trading and international business activities, although the exact legal supplier type is not explicitly stated.

CertificationsThe supplier holds ISO 13485 and GMP certifications. These are explicit quality and manufacturing-system credentials relevant to medical or healthcare-related production, providing positive evidence for this field.

R&D capabilityThe supplier reports new products within the past year, ODM capability, OEM service for well-known brands, an available SDK, and 11–20 years of total R&D engineer experience. These explicit indicators support a positive assessment of product development and innovation capability, although 3D software design is not provided.

Production capacityThe supplier reports annual dermal filler output of 850,000 pieces, inventory capability, 6–10 quality-control staff, and ISO 13485/GMP certification. Peak- and off-season lead times are both within 15 working days, but outsourcing procedures and contracts are unknown; the stated production and fulfillment evidence nevertheless supports this capability.

Customization capabilityThe supplier explicitly offers customization from samples, designs, minor customization, flexible customization, and full customization, and also provides ODM and OEM services. The only stated limitation is that it does not provide 3D software design services, which does not negate the broad physical-product customization offering.